Company Overview: PURE Bioscience, Inc. (OTCBB: PURE) develops and markets proprietary antimicrobial products that address health and environmental challenges.
Recent Performance Highlights:
Q3 2025 Results:
Net product sales increased to $489,000 from $440,000 year-over-year.
Gross profit rose...